In conclusion, IgA anti-MAA concentration is significantly associated with multiple cardiovascular risk factors in RA patients and modifies the relationship between ACC/AHA 10-year risk score and CAC in RA. This evidence concerns the gene CD79A and rheumatoid arthritis.